Choline Kinase Active Site Provides Features for Designing Versatile Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|23|2684-2693

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.23, 2014-12, pp. : 2684-2693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in Designing Substrate-Competitive Protein Kinase Inhibitors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2875-2882

Bentham Science Publishers

Access to resources Recommend Favorite

(Q)SAR Studies to Design New Human Choline Kinase Inhibitors as Antiproliferative Drugs

By  

Current Medicinal Chemistry, Vol. 13, Iss. 11, 2006-05 ,pp. : 1231-1248

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR-Derived Choline Kinase Inhibitors: How Rational can Antiproliferative Drug Design Be?

By  

Current Medicinal Chemistry, Vol. 10, Iss. 13, 2003-07 ,pp. : 1095-1112

Bentham Science Publishers

Access to resources Recommend Favorite

ATP Site-Directed Inhibitors of Protein Kinase CK2: An Update

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1340-1351

Bentham Science Publishers

Access to resources Recommend Favorite

Unorthodox Inhibitors of HIV Protease: Looking Beyond Active-site-directed Peptidomimetics

By  

Current Pharmaceutical Design, Vol. 20, Iss. 21, 2014-05 ,pp. : 3389-3397

Bentham Science Publishers

Access to resources Recommend Favorite